AU6098994A - Methods and agents for the diagnosis and treatment of rheumatoid arthritis - Google Patents
Methods and agents for the diagnosis and treatment of rheumatoid arthritisInfo
- Publication number
- AU6098994A AU6098994A AU60989/94A AU6098994A AU6098994A AU 6098994 A AU6098994 A AU 6098994A AU 60989/94 A AU60989/94 A AU 60989/94A AU 6098994 A AU6098994 A AU 6098994A AU 6098994 A AU6098994 A AU 6098994A
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- agents
- treatment
- methods
- rheumatoid arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 206010039073 rheumatoid arthritis Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US947193A | 1993-01-27 | 1993-01-27 | |
US009471 | 1993-01-27 | ||
PCT/US1994/001077 WO1994017411A1 (en) | 1993-01-27 | 1994-01-27 | Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6098994A true AU6098994A (en) | 1994-08-15 |
Family
ID=21737862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU60989/94A Abandoned AU6098994A (en) | 1993-01-27 | 1994-01-27 | Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6098994A (en) |
WO (1) | WO1994017411A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9401689D0 (en) * | 1994-01-28 | 1994-03-23 | Univ Manchester | Diagnosis and treatment of endocarditis |
FR2773078B1 (en) * | 1997-12-30 | 2000-05-26 | Univ Toulouse | USE OF CITRULLIN PEPTIDES DERIVED FROM FILAGGRIN FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS |
KR101836968B1 (en) | 2007-10-30 | 2018-03-12 | 필로겐 에스.피.에이. | An antigen associated with rheumatoid arthritis |
AR071169A1 (en) * | 2008-03-31 | 2010-06-02 | Council Scient Ind Res | VARIANTS OF STREPTOQUINASE CONTAINING CISTEINE AND ITS COVALENTLY MODIFIED FORMS |
EP2236517A1 (en) * | 2009-03-31 | 2010-10-06 | Takara Bio, Inc. | Anti-fibronectin fragment monoclonal antibody |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4645748A (en) * | 1985-02-01 | 1987-02-24 | Charles Hurwitz | Protein which is characteristic of rheumatoid arthritis |
DE3513915A1 (en) * | 1985-04-17 | 1986-10-23 | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin | IMMUNOLOGICAL TEST KIT |
US4980279A (en) * | 1986-04-15 | 1990-12-25 | Scripps Clinic And Research Foundation | Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods |
-
1994
- 1994-01-27 AU AU60989/94A patent/AU6098994A/en not_active Abandoned
- 1994-01-27 WO PCT/US1994/001077 patent/WO1994017411A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1994017411A1 (en) | 1994-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7545594A (en) | Implantable device for the treatment of aedemas | |
HU9401580D0 (en) | Method for the preparation and popification of alphia - interferon | |
AU2103295A (en) | Methods for the treatment of thrombosis | |
AU663833B2 (en) | Surgical and/or clinical apparatus | |
AU6965996A (en) | Method and apparatus for maintaining the position of body parts | |
AU4995693A (en) | Apparatus and method for the treatment of blood | |
AU6379494A (en) | Device for the application of electrical pulses in the treatment of biological issues | |
AU6041394A (en) | Ultrasonic monitor | |
PH31600A (en) | Methods of inhibiting atrophy of the skin and vagina. | |
AU6801694A (en) | The treatment of small animals | |
KR0166397B1 (en) | Transistor & method of forming the same | |
AU6946594A (en) | Methods for the treatment and prevention of diarrhea | |
AU1438295A (en) | Method for treatment of papulo-pustules and comedones of the skin | |
AU7992994A (en) | Immunoassay for the dectection of human autoantibodies | |
AU7376494A (en) | Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents | |
AU661364B2 (en) | Method for administration of azauridine for the treatment of rheumatoid arthritis | |
ZA944772B (en) | Treatment of fluids | |
AU4468093A (en) | Composition and methods for the generation of bone | |
AU8131694A (en) | Treatment for rheumatoid arthritis | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU6098994A (en) | Methods and agents for the diagnosis and treatment of rheumatoid arthritis | |
EP0642337A1 (en) | Dapsone and promin for the treatment of dementia. | |
EP0647708A3 (en) | Process and apparatus for the propagation of yeast. | |
AU4441093A (en) | Ultrasonic apparatus for health and beauty | |
AU7509294A (en) | Method and system for the biological treatment of waste |